Remicade
information and resources from the National Cancer Institute
Remicade
(Other name for: infliximab)
|
|
|
|
news articles
Schering-Plough's Remicade gets additional Australian approvals Mar 24, 2006
Pharmaceutical Business Review The therapeutic goods administration of the Australian department of health and ageing has revised the indication of Schering-Plough's Remicade to include the ...
REMICADE(R) Is Approved in Australia for Treatment of Early ... Mar 23, 2006
Finanzen.net, ...announced that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of REMICADE (R) (infliximab ...
Schering-Plough's REMICADE Gets FDA Approval In Australia In ... Mar 23, 2006
Trading Markets, ...(RTTNews) - Thursday afternoon, Schering-Plough Corp. (SGP | charts | news | Powerrating), announced that its drug REMICADE, in combination with methotrexate ...
Schering-Plough Says REMICADE Is Approved For Treatment Of Early ... Mar 23, 2006
Trading Markets, ...revealed that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of REMICADE to include the ...
Remicade (infliximab) gains Australian approval for treatment of ... Mar 23, 2006
News-Medical.net, ...announced that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of Remicade (infliximab) to ...
International Approvals: Femara and Remicade Mar 27, 2006
Medscape (subscription) On March 23, Australia's Therapeutic Goods Administration approved an expanded indication for infliximab (Remicade injection, made by Centocor, Inc, and ...
First Biologic Therapy Approved in Canada for Painful Inflammatory ... Mar 30, 2006
DG News MONTREAL, CANADA -- March 30, 2006 -- Remicade® (infliximab) is the first biologic approved to treat Canadians living with the debilitating effects of ...
EU approves Remicade drug for ulcerative colitis Mar 9, 2006
Reuters LONDON, March 9 (Reuters) - The European Commission has approved wider use of Johnson & Johnson's (JNJ.N: Quote, Profile, Research) drug Remicade to include ...
J&J says Remicade shows psoriasis promise Mar 3, 2006
Reuters ...on Friday said a late-stage study showed patients with moderate to severe psoriasis demonstrated significant improvement when taking the company's Remicade drug ...
Remicade gets added Remicade EU approval Mar 9, 2006
BusinessWeek ...and Centocor Inc., the biotech unit of Johnson & Johnson, said Thursday that European regulators approved Remicade for the treatment of ulcerative colitis. ...
REMICADE(R) Is First Biologic Approved In European Union To Treat ... Mar 9, 2006
Finanzen.net, ...and Schering-Plough Corporation today announced the European Commission has granted approval of REMICADE(R) (infliximab) for the treatment of moderately to ...
Remicade Is First Biologic Approved in European Union to Treat ... Mar 9, 2006
DG News ...and Schering-Plough Corporation today announced the European Commission has granted approval of Remicade® (infliximab) for the treatment of moderately to ...
Schering-Plough Reveals EU's Approval For REMICADE For Treating ... Mar 9, 2006
Trading Markets, ...(SGP | charts | news | Powerrating), a science-based health care company, revealed that the European Commission/EU has granted approval for REMICADE for the ...
Analysis: Remicade works for psorasis Mar 6, 2006
United Press International SAN FRANCISCO, March 6 (UPI) -- Remicade (infliximab) -- a drug already approved by the Food and Drug Administration for the treatment of rheumatoid arthritis ...
EU OK's Schering's Remicade for colitis Mar 9, 2006
United Press International KENILWORTH, NJ, March 9 (UPI) -- Schering-Plough said Thursday the European Commission approved Remicade for the treatment of ulcerative colitis. ...
Remicade gets European ulcerative colitis approval Mar 10, 2006
Pharmaceutical Business Review The European Commission has granted approval for Centocor and Schering-Plough's Remicade for the treatment of moderately to severely active ulcerative colitis. ...
REMICADE(R) Phase 3 Data Show Rapid and Significant Improvement ... Mar 7, 2006
Webbolt Business News (subscription), SAN FRANCISCO -- Phase 3 data show treatment with REMICADE(R) (infliximab) resulted in rapid, significant improvement and long- term response in patients with ...
Drug approved for arthritis treatment Mar 29, 2006
Ninemsn, ...two years. The Therapeutic Goods Administration (TGA) has approved the Tumour Necrosis Factor (TNF) inhibitor drug Remicade. This ...
REMICADE(R) Phase 3 Data Show Rapid and Significant Improvement ... Mar 3, 2006
PR Newswire (press release), Show High-Level, Sustained Response with Maintenance Therapy SAN FRANCISCO, March 3 /PRNewswire/ -- Phase 3 data show treatment with REMICADE(R) (infliximab ...
REMICADE Phase 3 Data Show Rapid, Significant, Long-term Psoriasis ... Mar 7, 2006
Medical News Today (press release), Phase 3 data show treatment with REMICADE® (infliximab) resulted in rapid, significant improvement and long-term response in patients with moderate to severe ...
REMICADE(R) Is First Biologic Approved In European Union To Treat ... Mar 9, 2006
Medical News Today (press release), ...and Schering-Plough Corporation (NYSE: SGP) today announced the European Commission has granted approval of REMICADE(R) (infliximab) for the treatment of ...
REMICADE(R) Phase 3 Data Show Rapid and Significant Improvement ... Mar 3, 2006
PR Newswire (press release), SAN FRANCISCO, March 3 /PRNewswire/ -- Phase 3 data show treatment with REMICADE(R) (infliximab) resulted in rapid, significant improvement and long- term ...
Centocor's Remicade achieves rapid results in psoriasis Mar 7, 2006
Pharmaceutical Business Review By Staff Writer. Centocor has posted more promising data for Remicade, this time in a phase III trial in moderate to sever plaque psoriasis. ...
REMICADE(R) Is First Biologic Approved In European Union To Treat ... Mar 9, 2006
PR Newswire (press release), New Approval Marks Eighth Indication for REMICADE in the EU to Treat a Number of Immune-Mediated Inflammatory Disorders HORSHAM, Pa. ...
Endoscopy in the Ambulatory Setting Mar 31, 2006
Today's SurgiCenter, Other things that you tend to hear about some ASCs doing are, for example, Remicade infusions; those are not approved procedures for an endo center. ...
Martial arts v arthritis... no contest! Mar 27, 2006
Belfast Telegraph, Then, an unexpected lifeline - in the shape of revolutionary new treatment called Remicade. The results were astonishing. Shane's life was transformed. ...
Alva doctor indicted for health care fraud Mar 23, 2006
Alva Review Courier, Medicare eligible patients. The indictment focuses on two prescription medications: Procrit and Remicade. Procrit is administered ...
Australia OKs drug as arthritis treatment Mar 24, 2006
Cherry Hill Courier Post, ...said Thursday that Australian regulators have revised their indication of the drug Remicade to include treatment of early rheumatoid arthritis, and approved a ...
Business news in brief Mar 24, 2006
Philadelphia Inquirer, ...said Australian regulators have revised their indication of the drug Remicade to include treatment of early rheumatoid arthritis and have approved a new ...
Schering-Plough debt rating outlook raised to stable - S&P Mar 24, 2006
Forbes ...'The ratings on the company continue to reflect its diverse product portfolio, featuring major products Vytorin/Zetia, Remicade, PEG-Intron, and Clarinex, as ...
UCB's Chemical Reaction Mar 22, 2006
International News Service, Although it will compete against Johnson & Johnson's (JNJ) Remicade, and Abbott Laboratories' (ABT) soon-to-launch Humira, analysts are optimistic that Cimzia ...
Centocor's psoriasis drug posts positive phase III data Mar 7, 2006
Pharmaceutical Business Review Phase III data have shown that treatment with Centocor's Remicade resulted in rapid, significant improvement and long-term response in patients with moderate ...
Business news in brief Mar 10, 2006
Philadelphia Inquirer, Centocor Inc., the biotechnology subsidiary of Johnson & Johnson, said European regulators have approved Remicade for the treatment of ulcerative colitis. ...
Prednisone Associated With Increased Risk Of Pneumonia Mar 16, 2006
About - News & Issues, ...arthritis patients. There was no increase in risk associated with Enbrel, Remicade, Humira, methotrexate, or sulfasalazine. Researchers ...
Business news in brief from around New Jersey Mar 9, 2006
Newsday, KENILWORTH, NJ -- Schering-Plough Corp. said Thursday it has received clearance from European regulators to market its top selling drug Remicade for a new use. ...
Business news in brief from around New Jersey Mar 9, 2006
Press of Atlantic City, ...said Thursday it has received clearance from European regulators to market its top selling drug Remicade for a new use. Remicade ...
Centocor releases phase-III results for psoriasis drug Mar 3, 2006
Philadelphia Business Journal, Centocor Inc. reported positive study results of tests using its drug Remicade in patients suffering from psoriasis. The results ...
Steroid treatment for arthritis ups pneumonia risk Mar 16, 2006
Reuters.uk, ...report in the medical journal Arthritis & Rheumatism that the most common treatments were methotrexate, prednisone, Remicade, hydroxychloroquine and Enbrel. ...
Playing Catch-up Mar 28, 2006
American Enterprise Institute, Remicade, first used to treat Crohn’s disease, now treats arthritis and colitis, while the HIV drug Viread may be effective against hepatitis B (Calfee ...
Treating Crohn's Disease Mar 10, 2006
WSOCtv.com, A newer drug, called infliximab (Remicade®) is used to prevent inflammation in patients with moderate to severe Crohn's disease. ...
S&P changes Schering-Plough's outlook to stable Mar 24, 2006
Reuters Sales prospects are also strong for the rheumatoid arthritis treatment Remicade, whose sales rights Schering-Plough licensed from Johnson & Johnson, S&P said. ...
(PRN) - February Single-Family Home Sales Mark a High for Illinois ... Mar 23, 2006
Bolsamania.com, NV ... [+. PRN) - REMICADE(R) Is Approved in Australia for Treatment of Early Rheumatoid Arthritis and Psoriatic Arthritis ... [+. ...
GSW Worldwide's New York Office Announces New Hires Mar 23, 2006
PharmaLive.com (press release), Prior to GSW Worldwide, Bashoff served as copy supervisor at Nelson Communications, a Publicis Healthcare company, where she worked on the Remicade and Allegra ...
London drug trial volunteers in critical condition Mar 14, 2006
MSNBC More than 15 have reached the market, including Herceptin, Rituxan and Avastin for cancer and Humira and Remicade for arthritis. ...
Schering-Plough's Hassan hits obstacles trying to revive company Mar 12, 2006
Miami Herald, ...merger. Hassan's team attempted to squeeze as much as possible out of existing products such as Remicade for rheumatoid arthritis. ...
Cancer Drug OK'd As Arthritis Treatment Mar 3, 2006
W*USA 9, ...t work. Those include a class of RA drugs called tumor necrosis factor blockers, including Enbrel, Remicade and Humira. The FDA ...
(PRN) - IMPART Media Group Closes $4.5 Million Equity Financing .. ... Mar 3, 2006
Bolsamania.com, ...[+]. (PRN) - REMICADE(R) Phase 3 Data Show Rapid and Significant Improvement and Long-Term Response in the Treatment of Moderate to Severe Psoriasis ... [+. ...
US Gives a Second Life to a Major Cancer Drug Green Light for ... Mar 2, 2006
International News Service, ...three older biotechnology drugs that work in much the same way and have combined annual sales of more than $6 billion Enbrel from Amgen, Remicade from Johnson ...
Cancer Drug May Double As an Arthritis Treatment Mar 2, 2006
International News Service, ...class of rheumatoid arthritis drugs called tumor necrosis factor, or TNF, blockers. Those drugs include Enbrel, Remicade and Humira.
(PRN) - Following Is a Test Release ... [+] Mar 9, 2006
Bolsamania.com, Outside Paris ... [+. PRN) - REMICADE(R) Is First Biologic Approved In European Union To Treat Ulcerative Colitis ... [+. PRN) - Large ...
Genentech/Biogen Idec: Rituxan further expands its options Mar 2, 2006
Pharmaceutical Business Review ...modifying treatments (DMARDs), followed by the more expensive biologics such as Amgen's Enbrel (etanercept) or Johnson & Johnson's Remicade (infliximab), which ...
New Use for Cancer Drug OK‘d Mar 3, 2006
Herald News Daily, ...t work. Those include a class of RA drugs called tumor necrosis factor blockers, including Enbrel, Remicade and Humira. Shares of ...
PRESCRIPTIONS FOR HEALTH Mar 8, 2006
Houston Chronicle, Those with complete fusion of the spine or who previously have used medications such as Remicade, Enbrel or Humira are not eligible. ...
CytoDyn CEO Acquires Cancer-Fighting Compound and Lilly Launches ... Mar 10, 2006
Financial News USA (press release), ...(NYSE:SGP) and Centocor Inc., the biotech unit of Johnson & Johnson, said Thursday that European regulators approved Remicade for the treatment of ulcerative ...
Manhattan Research Reveals Top Ten Consumer-Ranked Pharmaceutical ... Mar 7, 2006
PR Newswire (press release), Ortho Tri-Cyclen Lo, Patanol, Paxil, Plavix, Premarin, Prevacid, Procrit, Protonix, Provigil, Pulmicort, Raptiva, Rebif, Relpax, Remicade, Requip, Rhinocort ...
Subject: Jim Cramer's Action Alerts PLUS Weekly Roundup Mar 10, 2006
TheStreet.com (subscription), Schering-Plough (SGP:NYSE, $18.05, 12,500 shares, 5.67%): Won approval for an eighth indication for Remicade in Europe this week. ...
Cancer drug to remedy arthritis Mar 3, 2006
Albuquerque Tribune, ...tumor necrosis factor, or TNF, blockers. Those drugs include Enbrel, Remicade and Humira. In rheumatoid arthritis, the body's immune ...
New Drugs Offer More Choices for Psoriasis 21 Dec 2005
Spartanburg Herald Journal (subscription), In late 2002, her longtime dermatologist, Dr. Terry Hadley of Concord, Mass., started her on infusions of infliximab, sold as Remicade, a new so-called ...
Biologic drugs the latest psoriasis weapon 21 Dec 2005
United Press International However, a host of biologic drugs -- led by Centocor Inc.'s Remicade -- have resulted in major improvements for numerous psoriasis sufferers, The New York ...
Juvenile Arthritis - A Niche In The Market 21 Dec 2005
Pharmaceutical Business Review Juvenile arthritis is the next indication due for approval for blockbuster biologic therapies Remicade (infliximab) and Humira (adalimumab). ...
Landmark Trials Demonstrate Benefits of Remicade (Infliximab) in ... Dec 8, 2005
DG News December 8, 2005 -- Landmark studies published today in The New England Journal of Medicine demonstrate the benefits of treatment with Remicade(R) (infliximab ...
Remicade Treats Ulcerative Colitis Dec 7, 2005
WebMD Dec. 7, 2005 -- The rheumatoid arthritis drug Remicade may help treat moderate-to-severe ulcerative colitis, a new study shows. ...
Remicade Effective for Ulcerative Colitis Dec 8, 2005
MedPage Today, 7 - Remicade (infliximab) appears to be an effective option for patients with ulcerative colitis not responding to conventional treatment, according to a pair ...
Active psoriatic arthritis patients on REMICADE® achieve major ... Nov 19, 2005
Medical News Today (press release), ...two-year treatment duration, show a significantly higher proportion of patients with active psoriatic arthritis receiving REMICADE® (infliximab) achieved and ...
Landmark Trials Published in New England Journal of Medicine ... Dec 7, 2005
PR Newswire (press release), Long-Term Phase 3 Data Show Treatment with REMICADE Achieves Clinical Response, Steroid-Free Remission, and Mucosal Healing Through One Year HORSHAM, Pa., and ...
Landmark Trials Published in New England Journal of Medicine ... Dec 7, 2005
PR Newswire (press release), 7 /PRNewswire/ -- Landmark studies published today in The New England Journal of Medicine demonstrate the benefits of treatment with REMICADE(R) (infliximab ...
Study: Remicade eases arthritis pain Nov 17, 2005
myDNA.com, ...two-year treatment duration, show a significantly higher proportion of patients with active psoriatic arthritis receiving Remicade (infliximab) achieved and ...
Landmark Trials Published in New England Journal of Medicine ... Dec 7, 2005
PR Newswire UK (press release), Landmark studies published today in The New England Journal of Medicine demonstrate the benefits of treatment with REMICADE (R)(infliximab) in patients with ...
Trials Published in NEJM Demonstrate Benefits of REMICADE® in ... Dec 7, 2005
EndoNurse, KENILWORTH, NJ -- Landmark studies published today in The New England Journal of Medicine demonstrate the benefits of treatment with REMICADE® (infliximab) in ...
Crohn's Drug Fights Ulcerative Colitis Dec 7, 2005
Forbes 7 (HealthDay News) -- Individuals struggling with the chronic discomfort of ulcerative colitis may gain relief from the drug Remicade, a new study suggests. ...
UCSD Doctors Find New Therapy For Kawasaki Patients Dec 16, 2005
10News.com, But for 15 percent of patients, gamma globulin doesn't work so doctors are using a drug called Remicade, as a potential treatment for Kawasaki disease ...
New drugs effective against gout, colitis Dec 7, 2005
MSNBC Infliximab, sold under the brand name Remicade for arthritis and Crohn’s disease, was shown to sharply reduce bloody diarrhea, abdominal cramps and other ...
Studies: Drugs Help Against Gout, Colitis Dec 10, 2005
Brocktown News, Infliximab, sold under the brand name Remicade for arthritis and Crohn‘s disease, was shown to sharply reduce bloody diarrhea, abdominal cramps and other ...
Colleges seek to make scientific research pay off Dec 19, 2005
MSNBC ...on research. NYU made most of its money from royalties on the drug Remicade, used to treat arthritis and other conditions. A more ...
County insulin-pump firm to be purchased Dec 17, 2005
Chester Daily Local Online, It continues to operate a manufacturing facility in East Whiteland, where it makes Remicade, used to treat rheumatoid arthritis. ...
CROHN'S DISEASE CAN AFFECT ENTIRE DIGESTIVE TRACT Dec 7, 2005
Charlotte Sun-Herald, ...come into play. Two examples are azathioprine and 6-mercaptopurine. The newest Crohn's medicine is Remicade. With treatment, most ...
Enbrel, Humira to dominate TNF-alpha market Nov 28, 2005
World Peace Herald, Another agent, Remicade, which is marketed in the United States by Centocor and elsewhere by Schering-Plough, will do well over the next decade but "its going ...
A Quarterback's Personal Rally Dec 10, 2005
New York Times, The doctors prescribed yet another new drug, Remicade, to try to keep the disease in remission. Garrard began to put on weight. ...
ACR: CNTO-148 Demonstrates Efficacy for RA Nov 18, 2005
MedPage Today, That positive finding from a dose-finding study suggests that the drug may be a good alternative to Remicade (infliximab), which is made by Johnson & Johnson ...
IBD: Current and Future Trends Dec 1, 2005
EndoNurse, ...“Technology has reached a point of having multiple different drugs to treat these conditions, such as Remicade, which was recently approved for UC use, and ...
ACR Rituxan Shows Durable Response for Refractory RA Nov 18, 2005
MedPage Today, 18 - Rheumatoid arthritis patients who get no relief from DMARDs -- such as Remicade, Enbrel, or Humira -- may benefit from Rituxan (rituximab), a B-cell ...
(PRN) - James F. Millar Joins First Industrial's Board of ... Dec 7, 2005
Bolsamania.com, ...(PRN) - Landmark Trials Published in New England Journal of Medicine Demonstrate Benefits of REMICADE(R) in Patients With Ulcerative Colitis ... [+. ...
Health Proposals 'Will Hit Vulnerable' Dec 6, 2005
News Letter, ...institutions back into the community will not be sustained and we will not be able to cope with the demand for high cost drugs like Remicade for those ...
Borean Pharma Establish Proof of Concept With Their Proprietary ... Dec 6, 2005
Yahoo! News (press release) ...antagonist resulted in dose-dependent slowing of disease progression that was significantly different from controls and equivalent to Remicade, a monoclonal ...
IBEX Reviews 2006 Events at Shareholders' Meeting and Outlines ... Dec 7, 2005
CCNMatthews (press release), ...(marketers of the anti-arthritic compound Remicade ® ) regarding the levels of certain biomarkers in a subset of patients from the ASPIRE ® study, the ...
Pharma Reformulates Dec 5, 2005
Chemical & Engineering News Like J&J and Schering-Plough's similar product Remicade, which is classified as an immunosuppressant, these products have seen a steady broadening of their use ...
Pfizer's Troubles Pull Down Drugmakers Nov 21, 2005
Chemical & Engineering News ...in the halt include the cholesterol drugs Vytorin and Zetia, sold in a partnership with Merck, and the Centocor arthritis drug Remicade, which Schering-Plough ...
Anti-TNF Drugs Cut Mortality Rates among Rheumatoid Arthritis ... Nov 18, 2005
DG News Suppression of TNF proteins with infliximab (Remicade), etanercept (Enbrel) and adalimumab (Humira), and ensuing reductions of joint inflammation has made ...
Biotech patent dispute involves millions Nov 17, 2005
Business Gazette, Humira; Centocor Inc. for Remicade, a biological treatment for inflammatory disorders of the immune system; and ImClone Inc. for its ...
|
|
